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Abstract
Background: A range of barriers influence women’s uptake to a first breast screening invitation. Few studies however,
have examined factors associated with second screening uptake. This study follows Maltese women to explore
predictors and behaviours to re-attendance, and to determine if uptake of first invitation to the Maltese Breast
Screening Programme (MBSP) is a significant predictor of second screening uptake.
Methods: A prospective study was conducted to determine factors associated with re-attendance for 100 women
invited to the second MBSP round. Records of women’s second attendance to the MBSP were extracted in January
2016 from the MBSP database. Data were analyzed using chi-square tests, Independent Samples t-test, Mann Whitney
test, Shapiro Wilk test and logistic regression.
Results: There were no significant associations for sociodemographic or health status variables with second screening
uptake (p > 0.05), except breast condition (Fisher’s exact test, p = 0.046). Non-attendees at second screening were most
unsure of screening frequency recommendations (χ2 = 9.580, p = 0.048). Attendees were more likely to perceive their
susceptibility to breast cancer (p = 0.041), believed breast cancer to be life changing (p = 0.011) and considered cues to
action to aid attendance (p = 0.028). Non-attendees were in stronger agreement on mammography pain (p = 0.008)
and were less likely to consider cues to action (15.4% non-attendees vs 1.4% attendees) (p = 0.017 respectively).
‘Perceived barriers’, ‘breast cancer identity’, ‘causes’ and ‘consequences’ were found to be significant predictors of
second screening uptake, with ‘perceived barriers’ being the strongest. The inclusion of illness perception items
improved the regression model’s accuracy in predicting non-attendance to the second screening round (84.6% vs
30.8%). First screening uptake was found to be a significant predictor of subsequent uptake (OR = 0.102; 95% CI = 0.037,
0.283; p = 0.000).
Conclusions: Interventions to increase uptake should target first invitees since attending for the first time is a strong
predictor of uptake to the second cycle. Further research is required given the small sample. Particular attention should
be paid to women who did not respond to their first invite or are unsure or reluctant participants initially.
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Background
Breast cancer continues to be a major cause of female
morbidity and mortality worldwide [1]. Regular breast
screening (BS) for breast cancer (BC) could lead to a
25–30% reduction in mortality rates in the population of
women invited for screening [2]. This evidence led to
the implementation of screening programmes across
Europe based on the EU Council recommendations,
which recommend biennial screening mammography in
average-risk women aged 50–69 years [3]. A Maltese
breast screening programme (MBSP) was set up in
Malta in 2009 to screen women (aged 50 – 60 years)
through mammography every 3 years [4], aiming gradual
expansion to reach women until the age of 69 years
while reducing the screening time interval as in other
countries [5]. In 2015, this age cohort (50–60 years) was
in its second BS round.
Breast screening uptake is defined as “the proportion of
women invited who attend for screening within 6 months
of their invitation” ([6], p.1). In Malta, the overall attend-
ance rate was below the acceptable target of 70% in the
first BS round [7]. Similarly, substantial variation in BC
uptake exists across other countries [1]. An important fac-
tor that merits exploration includes regular screening ad-
herence, because of its significant impact on morbidity
and mortality reductions [8, 9]. Detecting BC early is not
ensured by a one-off BS attendance [10], but on the
consistency of attendance in line with recommended time
intervals [11]. The literature suggests that previous
mammography use is highly associated with future use
[12] because women believe in the effectiveness of
screening which in turn increases their intentions to go
for screening, resulting in their adherence to subsequent
screens [13]. An earlier study by Cockburn and colleagues
[14] found that those having weakest intentions to attend
for their first screening are less likely to attend for their
second screening (OR = 0.44, CI 0.23, 0.85). Therefore, it
has been suggested that programs should focus on
reaching those who have underutilized mammography in
their past [12] as this would feed into attendance in
subsequent BS invitation rounds. Nonetheless, many
studies have focused on the reasons for one-time
screening rather than subsequent use [9, 15] and limited
studies have sought to specifically explore predictors of
uptake to second round BS invitations [14, 16, 17]. In a
comparative study of 200 re-attenders and 200
non-re-attenders for second triennial National Breast
Screening Programme appointments in Nottingham [10],
the 200 women who failed to accept their invitation
implicated their negative initial screening experience in
their decision, with 41% implicating pain, 6% stress and
3% embarrassment.
To our knowledge, no research yet exists on women’s
reattendance at the MBSP or on screening predictors to
the second BS round in Malta. In 2017, we reported on
first screening uptake of the MBSP [4]. We found that
Health Belief Model (HBM) constructs were the strongest
predictors of uptake of first invitation to the MBSP,
though the inclusion of illness representation dimensions
improved the predictive accuracy for non-attendance. In
the present study, we follow a sub-sample of Maltese
women with three main objectives: (1) to determine their
re-attendance at the second BS invitation round; (2) to
explore whether sociodemographic factors, health status,
knowledge, health beliefs and illness perceptions are
significant predictors of second BS uptake; and (3) to
determine if uptake of first invitation to attend the MBSP
is a significant predictor of uptake to the second invitation
in Malta.
Theoretical framework
BS behaviour is influenced by a number of factors, in-
cluding health beliefs [8], illness representations [8],
knowledge of BC and BS [4], socio-demographic factors
[4], and health status (medical factors) [8]. These factors
were found to influence BS attendance in the first
invitation round in Malta [4]. The Health Belief Model
(HBM) was used as a theoretical framework for this
study, due to its application in myriad preventive health
behaviours, including BS [8, 18–20]. The HBM consists
of six main variables (constructs), namely perceived
susceptibility, perceived severity, perceived benefits,
perceived barriers, cue to action, and self-efficacy [19].
These variables play an important role in an individual’s
perception about BS, such that women are more likely
to perform BS if they feel susceptible to BC or the risks
of contracting BC (perceived susceptibility), believe in
the seriousness and consequences of the disease
(perceived severity), perceive more benefits than
barriers from undergoing mammography, have higher
confidence for obtaining mammography, and take heed
in cues to action [19]. Based on the HBM, women’s
perceptions about BC are derived from their knowledge
and perceptions about the disease, which predicts
whether women will attend for mammography [18].
However, the HBM does not include the impact of
emotions to predict BS behaviours, which is why the
Common-Sense Model (CSM) [20], also used to explain
BS behaviour in a small number of studies [8, 21–25],
was utilised in this study. The CSM considers the
cognitive and emotional representations of a health
threat [8, 26, 27] and guides subsequent coping
behaviour [28]. Illness perceptions comprise the
following constructs: BC identity, cause, cancer timeline
(acute/chronic, cyclical), consequences, personal and
treatment control, illness coherence and emotional
representations. [8, 21].
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Methods
Study design and setting
The full details of the methods are described in detail in
our prior paper [4]. This prospective study was con-
ducted in Malta in January 2016 to determine factors as-
sociated with the second BS cycle.
Participants
Of the 404 women surveyed between June and Septem-
ber 2015 about their first BS attendance [4], 100 women
were identified in January 2016 to have subsequently
been invited to the second round. These 100 women
were a sub-sample of participants of our larger study [4]
who had received an invitation to attend both the first
and second MBSP round. Description and
characteristics of the larger sample (n = 404) are found
in the previous study [4].
Measures
To predict reattendance, we used our previously con-
structed 121-item questionnaire based on Champion’s
Health Belief Model Scale (CHBMS-MS) and the
Revised Illness Perception Questionnaire (IPQ-R). The
full details of its translation, adaptation and pilot-testing
among Maltese women have been described in detail in
our prior published paper [29].
Variable definitions
A second invitation was defined as the second (subsequent)
time a woman is invited to the MBSP and either attends or
does not attend for the mammogram. Women were consid-
ered eligible in this study if their scheduled appointment
date had elapsed for their second BS invitation and they
had not informed the unit to reschedule their mammog-
raphy invitation. A screening invitation is posted to the cli-
ent approximately 1 month before the scheduled
mammography date. Hence, those women invited to the
second BS round and awaiting their scheduled day for
mammography screening were not considered in this study.
Data analysis
Several statistical tests were used to analyse the differences
between attendance or non-attendance to the second
MBSP invitation. Chi-square test was used to test for
association between two categorical variables (e.g.
attendance against women’s knowledge of the breast
screening frequency); however, Fisher’s exact test was used
when the assumptions of the Chi-Square test were
violated. The Shapiro-Wilk test was used to test for
normality of all construct variables. Furthermore, the
following tests were used throughout the analysis: the
independent samples t-test and the non-parametric
Mann-Whitney test. Significant predictors for re-attendance
were determined through the binary logistic regression.
Hence, several models were developed (using different
constructs and variables) to predict attendance and
non-attendance to the second MBSP invitation. The
‘backward-elimination’ was applied to exclude any
non-significant variables from the latter models and the
final output included the unstandardized coefficients,
standard error, the Wald value, p-values, Odds Ratios (ORs)
and 95% confidence intervals (95% CIs). The data was
analyzed using SPSS version 21 under the guidance of an
expert statistician. A P-value of < 0.05 was considered
statistically significant (Table 1).
Results
Sample characteristics
Table 1 presents the sample characteristics (n = 100). At
the time of the second screening cycle, women were
aged between 53 and 63 years with a mean of 58.63 years
(±2.63 SD (standard deviation)).
From the 100 women invited to the second screening
round (Fig. 1), nearly three-quarters of this sample (74%;
n = 74) attended the second screening round; of these,
83.8% (n = 62) had responded to their first invitation
while 16.2% (n = 12) had not attended the first screening
round. Over a quarter of our sample (26%; n = 26) did
not attend the second screening round; of these, 34.6%
(n = 9) had attended the first screening cycle while
65.4% (n = 17) had not responded to their first
invitation. Women who attended their first invitation
were more likely to sustain screening mammography
adherence than non-attendees (χ2 = 22.6, p < 0.001).
Associations between psychosocial factors, and
attendance and non-attendance to a second BS
invitation
Similar to the analysis carried out in our previous papers
to analyse the associations between attendees and
non-attendees in relation to lifetime mammography
practices [30] and timely adherence [31], the following
analysis focused on the associations between attendees
and non-attendees to a second BS invitation.
Sociodemographic factors and health status
There was a significant association between breast condi-
tion (lumps or cysts but not BC) and second screening up-
take (Fisher’s exact test applied: p = 0.046), whereby from
those who attended their second invitation, 15.1% had a
breast condition, whereas from among non-attendees,
34.6% had a breast condition. There were no significant
associations for other sociodemographic or health status
variables (p > 0.05).
Knowledge
There was a significant association between knowledge
about recommended frequency for attending BS; women
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who did not attend the second screening invitation were
most unsure of the recommended frequency (χ2 = 9.580,
p = 0.048).
Health beliefs
No statistical significance was found for the majority of
the HBM constructs, except for 5 items (Table 2) as fol-
lows: 25.7% of women who attended the second round
strongly disagreed with the statement: ‘there is no is possi-
bility of getting breast cancer’ as opposed to 11.5% of
non-attendees (p = 0.041), while 23.1% of non-attendees
were undecided. Attendees considered more strongly than
non-attendees (41.9% vs 19.2%) that they would sustain
mammography adherence if their GP advised them to
attend (p = 0.028). Non-attendees were in stronger
agreement than attendees (11.5% vs 0.0%) that
mammography is painful or uncomfortable (p = 0.008).
Non-attendance at the second invitation round was more
likely for women who considered reminder letters,
reminder phone calls and text messages not to be of help
(15.4% non-attendees vs 1.4% attendees) (p = 0.017
respectively).
Illness perceptions
No statistical significance was found for all illness per-
ception items except for one variable (Table 3): those
who attended the second screening round agreed more
strongly than non-attendees (39.2% vs 7.7%) that their
whole life would change if breast cancer occurred (p =
0.011).
Differences between attendees and non-attendees
We further explored health beliefs and illness percep-
tions as ‘constructs’ and which of these constructs were
statistically significant with second BS uptake. Table 4
shows the relationship between all 14 constructs respect-
ively (perceived susceptibility, perceived benefits, per-
ceived barriers, cues to action, self-efficacy, breast cancer
identity, causes of breast cancer, cancer timeline: acute/
chronic, cancer timeline: cyclical, consequences, personal
control, treatment control, illness coherence, emotional
representations), and attendance and non-attendance to
second BS round.
The ‘perceived barrier’ construct was the only statisti-
cally significant variable that described the variance be-
tween attendees and non-attendees.
Predictors of attendance and non-attendance to
the second screening round
Similar to the analyses carried out in our previous paper
to predict lifetime mammography attendance in Malta
[30], the following analyses focused on predicting at-
tendance and non-attendance to the second BS
invitation. The most significant variables for all logistic
Table 1 Sample Characteristics (n = 100)
Characteristics Mean SD N %
Age (year) 58.63 2.63
Education level
Primary level 26 26.0
Secondary level 68 68.0
Tertiary level 6 6.0
Occupation
Pensioner 4 4.0
Housewife 78 78.0
Employee 18 18.0
Status
Single 4 4.0
Married 85 85.0
Separated/Divorced 5 5.0
Widowed 6 6.0
Family income
Less than €10,737 28 28.0
€10,737 – €16,113 32 32.0
€16,114 – €23,563 8 8.0
€23,564 – €33,966 2 2.0
Greater than €33,966 2 2.0
Prefer not to say 30 30.0
Own a car
Yes 78 78.0
No 22 22.0
Drive
Yes 46 46.0
No 54 54.0
Any illness, disability or condition
Yes 58 58.0
No 42 42.0
Family physician (GP)
Yes 92 92.0
No 8 8.0
Frequency of GP visit
Only when I have a problem 80 80.0
Once a month 5 5.0
More than once a year 7 7.0
Missing 8 8.0
Lumpy breasts
Yes 9 9.0
No 91 91.0
Relatives or close friends had cancer
Yes 89 89.0
No 9 9.0
Prefer not to say 2 2.0
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regression models are presented in Table 5. Logistic
regression models 1 and 2 incorporated all items related
to demographic and health status variables respectively,
though none were found to be significant predictors of
second BS uptake.
Models 3 to 7 include the psychosocial variables. Model
3 incorporated all HBM variables, of which three variables
were found to be good predictors of second BS uptake:
‘there is no possibility of getting breast cancer’, ‘fear of the
unknown procedure’, and ‘GP advice to attend’ (Table 5).
For this model, attendance was predicted with an accuracy
of 93.2% and non-attendance with 30.8% accuracy. When
removing ‘fear of the unknown procedure’ from the
model, the accuracy decreased from 30.8 to 19.2% and
hence was retained even though p > 0.05.
Model 4 included all IPQ-R variables, of which four
IPQ-R variables were found to be good predictors:
‘breast swelling, dimpling, redness or soreness of the
skin’, ‘diet’, ‘altered immunity’, and ‘if you had BC, your
whole life would change’ (Table 5). The accuracy for
this model was 89.2% for attendance and 69.2% for
non-attendance.
Model 5 focused on the significant variables found in
model 3 and 4 together; i.e. on 12 variables (five Health
Beliefs and seven Illness Perception variables). The final
model (Model 5) retained the same significant predictors
as in Model 4, excluding the HBM variables, hence
showing that illness perceptions are important predictors
for second BS uptake. The model accuracy, when
combining both scores, was identical to that of Model
4, predicting attendance by 89.2% and non-attendance
by 69.2%.
Model 6 incorporated all individual Health Belief
and Illness Perception items, of which 14 variables
were significantly different. However, the latter vari-
ables made this model more complex due to the
large number of predictors. The model accuracy im-
proved substantially to 95.9% for attendees and
84.6% accuracy for non-attendees. The model
accuracy decreased from 84.6 to 76.9% when the
following variables were removed from the model: ‘if
you find a lump through a mammogram, the
treatment for breast cancer may not be as bad’ and
‘having a mammogram will decrease your chances of
dying from breast cancer’. Hence, the latter variables
were retained even though p > 0.05.
A logistic regression model (Model 7) was constructed
with all 14 constructs (i.e. HBM and IPQ-R as constructs
not individual items). The following constructs were the
most significant predictors of second screening uptake:
‘perceived barriers’, ‘breast cancer identity’, ‘causes of breast
cancer’ and ‘consequences’. The ‘perceived barriers’
construct was found to be the strongest predictor.
However, non-attendance was predicted with an
accuracy of 30.0%, which is inferior when compared to
Models 5 and 6 (69.2%). Moreover, when removing the
Fig. 1 First and second breast screening invitation pathway
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Table 2 Comparison of Health Beliefs between attendees and non-attendees
Attendance to the second breast screening invitation Yes No Total Chi-Square
testa
Health Beliefs Mean SD Mean SD Mean SD χ2 p-
value
There is no possibility of getting breast cancer (r) 1.8 0.6 2.2 0.7 1.9 0.6 0.3 0.041*
Your chances of getting breast cancer are high 3.6 0.7 3.5 0.7 3.6 0.7 1.1 0.789
There may be the possibility of developing breast cancer in your lifetime 4.0 0.3 3.9 0.4 4.0 0.3 3.8 0.147
When you get a mammogram, you feel good about yourself 4.0 0.3 3.9 0.5 4.0 0.4 6.5 0.088
When you get a mammogram, you do not worry as much about breast cancer 3.8 0.7 3.7 0.7 3.8 0.7 1.2 0.759
Having a mammogram will help you find lumps early in your breasts 4.2 0.5 4.1 0.5 4.2 0.5 3.3 0.355
If you find a lump through a mammogram, the treatment for breast cancer may not be as bad 4.0 0.4 4.0 0.2 4.0 0.3 1.2 0.750
Having a mammogram will decrease your chances of dying from breast cancer 4.0 0.4 3.9 0.4 4.0 0.4 4.3 0.227
Having a mammogram will help you find a lump before it can be felt by yourself or a health
professional
4.0 0.4 3.9 0.4 4.0 0.4 3.3 0.344
Having a routine mammogram would make you anxious about breast cancer 2.7 1.0 3.0 1.1 2.8 1.0 1.6 0.449
Having a routine mammogram would make you worry 2.7 1.0 2.9 1.1 2.7 1.0 1.5 0.685
You fear having a mammogram because you might find out that something is wrong 2.8 1.1 3.2 1.2 2.9 1.1 6.2 0.103
You fear having a mammogram because you do not know the procedure or what to expect 2.1 0.5 2.4 0.8 2.2 0.6 4.8 0.092
You fear having a mammogram because you know someone (family or friend) with breast cancer 2.6 1.1 2.7 1.2 2.6 1.1 0.6 0.907
It is embarrassing for you to have a mammogram 2.3 0.8 2.4 0.9 2.4 0.8 0.5 0.779
Undergoing mammography will be painful or uncomfortable 3.2 1.0 3.3 1.1 3.2 1.0 11.9 0.008*
Having a mammogram is time consuming 1.3 0.5 1.3 0.7 1.3 0.5 3.8 0.153
You are discontent with Breast Screening personnel as they have been rude to you 1.1 0.4 n/a n/
a
1.1 0.4 n/a n/a
You have fear or distrust in the medical team 1.7 0.8 2.0 0.8 1.8 0.8 4.7 0.094
Having a mammogram would expose you to unnecessary radiation 2.2 0.6 2.4 0.8 2.3 0.7 1.6 0.652
You have too many other problems in your life than to get a mammogram done 1.7 0.6 1.8 0.7 1.7 0.6 0.7 0.699
You are not old enough to have a mammogram periodically 1.8 0.4 1.8 0.4 1.8 0.4 0.9 0.344
If your GP advises you to attend for a mammogram, you will attend 4.4 0.5 4.1 0.6 4.3 0.6 9.1 0.028*
If your relatives or friends advise you to attend for a mammogram, you will attend 3.6 0.9 3.3 1.0 3.5 0.9 1.9 0.586
If someone close to you has been diagnosed with breast cancer, you will attend for a mammogram 4.3 0.9 4.2 0.9 4.3 0.9 0.9 0.826
Hearing about breast cancer and breast screening in the media or news makes you think about getting
a mammogram
3.6 0.8 3.4 1.0 3.6 0.9 1.7 0.418
Reminder letters would help you to get a mammogram 4.0 0.3 3.7 0.8 3.9 0.5 8.1 0.017*
Reminder phone calls or text messages would help you to get a mammogram 4.0 0.3 3.7 0.8 3.9 0.5 8.1 0.017*
Routine educational talks regarding breast cancer awareness would help you to get a mammogram 3.6 0.8 3.4 1.0 3.6 0.9 1.7 0.418
You feel confident that if you had a mammogram done, any abnormalities in your breasts will be
detected
3.7 0.6 3.5 0.7 3.7 0.6 3.1 0.378
You can arrange other things in your life to get a mammogram 4.2 0.6 4.0 0.9 4.1 0.7 6.2 0.103
In case you need a mammogram, you will find a place to get it done 4.2 0.5 4.1 0.5 4.2 0.5 3.3 0.355
You can make an appointment for a mammogram 4.2 0.5 4.2 0.5 4.2 0.5 3.3 0.355
You can arrange transportation to get a mammogram 4.2 0.5 4.2 0.5 4.2 0.5 3.3 0.355
You can talk to people at the breast screening centre about your concerns 4.1 1.0 n/a n/
a
4.1 1.0 n/a n/a
You can find a way to pay for a mammogram if you need to 4.3 0.4 4.2 0.5 4.2 0.5 2.9 0.234
R Reverse scored
*Significant at α = 0.05
aChi-square test was applied for all health beliefs; hence the categorical answers were used to apply this test for association. For each question,
respondents were asked to select a number between 1 and 5, where 1 = strongly disagree and 5 = strongly agree
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Table 3 Comparison of Illness Perceptions between attendees and non-attendees
Attendance to the second breast screening invitation Yes No Total Chi-Square testa
Illness Perception Mean SD Mean SD Mean SD χ2 p-value
The presence of a lump or thickening in the breast 3.9 0.3 3.9 0.4 3.9 0.4 4.8 0.186
Nipple discharge 3.9 0.4 3.8 0.4 3.9 0.4 0.8 0.666
Sudden nipple retraction 3.8 0.4 3.7 0.5 3.8 0.4 1.3 0.509
Change in shape or appearance of the nipple 3.9 0.3 3.8 0.4 3.9 0.3 1.0 0.603
Breast swelling, dimpling, redness or soreness of the skin 3.9 0.3 3.7 0.5 3.9 0.4 4.2 0.124
Skin changes of the breast 3.8 0.4 3.7 0.5 3.8 0.4 1.3 0.509
A sudden change in breast size 3.9 0.4 3.8 0.4 3.9 0.4 3.4 0.180
Aching breasts 3.6 0.6 3.4 0.6 3.6 0.6 4.1 0.132
Stress or worry 2.9 0.9 2.8 0.8 2.9 0.9 0.8 0.673
Your mental attitude (e.g. thinking about life negatively) 2.4 0.6 2.2 0.5 2.4 0.6 1.9 0.379
Family problems or worries 2.9 0.9 2.7 0.8 2.8 0.9 1.5 0.477
Overwork 2.4 0.7 2.2 0.6 2.4 0.7 1.5 0.483
Your emotional state (e.g. feeling down, lonely, anxious, empty) 2.5 0.8 2.3 0.5 2.5 0.7 3.6 0.167
Your personality 2.5 0.8 2.3 0.5 2.4 0.7 1.9 0.597
Hereditary - it runs in the family 4.6 0.5 4.4 0.7 4.6 0.6 5.1 0.080
Diet or eating habits 3.3 0.9 2.8 0.9 3.2 0.9 7.1 0.069
Poor medical care in the past 3.3 0.9 3.3 0.8 3.3 0.9 0.9 0.818
Your own behaviour 2.6 0.7 2.7 0.6 2.6 0.7 3.6 0.164
Ageing 3.0 0.9 3.2 0.9 3.1 0.9 1.2 0.562
Smoking 3.7 0.6 3.5 0.8 3.7 0.7 3.5 0.174
Alcohol 3.5 0.8 3.2 0.9 3.4 0.8 2.6 0.272
A germ or virus 3.1 0.8 3.0 0.8 3.1 0.8 0.8 0.686
Pollution in the environment 3.7 0.7 3.3 1.0 3.6 0.8 6.2 0.104
Altered immunity 3.6 0.7 3.8 0.5 3.7 0.6 5.7 0.129
Chance or bad luck 2.9 1.0 3.1 1.0 2.9 1.0 4.1 0.386
Accident or injury 3.0 1.0 3.0 0.9 3.0 0.9 0.9 0.831
Breast cancer will last a short time 2.7 0.7 2.7 0.5 2.7 0.7 3.8 0.286
Breast cancer is likely to be permanent rather than temporary 3.4 0.7 3.2 0.8 3.3 0.7 3.4 0.178
A patient with breast cancer goes through cycles in which her illness gets better and worse 3.6 0.7 3.4 0.7 3.5 0.7 3.0 0.394
Breast cancer has major consequences on a patient’s life 4.4 0.6 4.1 0.6 4.3 0.6 6.3 0.096
Breast cancer will not have much effect on your life 1.5 0.7 1.5 0.8 1.5 0.7 3.7 0.297
Breast cancer would strongly affect the way others see you 3.4 0.9 3.6 0.8 3.5 0.8 1.4 0.506
Breast cancer has serious economic and financial consequences 3.9 0.5 3.8 0.5 3.9 0.5 1.9 0.587
Breast cancer would strongly affect the way you see yourself as a person 4.1 0.5 4.1 0.6 4.1 0.5 0.6 0.736
Breast cancer would threaten a relationship with your husband or partner 3.1 1.0 2.9 0.9 3.1 0.9 1.4 0.714
If you had breast cancer, your whole life would change 4.4 0.6 4.0 0.4 4.3 0.6 11.2 0.011*
If you developed breast cancer, the chances of living a long life would decrease 4.1 0.4 4.0 0.0 4.0 0.3 3.9 0.142
There is a lot which you can do to control the symptoms if Breast Cancer occurs 3.9 0.5 4.0 0.0 3.9 0.4 1.8 0.604
The course of Breast Cancer will depend on your actions 4.0 0.4 4.0 0.0 4.0 0.3 1.5 0.691
Your actions will have an effect on the outcome of Breast Cancer 4.0 0.4 4.0 0.0 4.0 0.3 2.2 0.524
There is no treatment that will help to improve Breast Cancer 2.1 0.6 2.0 0.6 2.0 0.6 0.5 0.930
The treatment provided will be effective in controlling or curing Breast Cancer 4.0 0.2 4.0 0.2 4.0 0.2 0.4 0.804
The negative effects of Breast Cancer can be prevented or avoided by the treatment given 4.0 0.2 4.0 0.2 4.0 0.2 1.0 0.621
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constructs ‘causes of breast cancer’ and ‘consequences’
from the model (p-value slightly greater than 0.05), the
accuracy to predict non-attendance would decrease
from 30.0 to 15.4% even though p > 0.05.
Although ‘perceived barriers’ remains the most im-
portant construct to describe the variance between
attendees and non-attendees, illness perception
constructs (breast cancer identity, its causes and
consequences) can also be considered as strong
predictors of second BS uptake; a result further
echoed in Model 5, where the predictors are all
related to illness perceptions (breast cancer identity
and consequences). Hence, although Health Beliefs
are important predictors of BS uptake, the model
accuracy improved with the inclusion of illness
perception items into one logistic regression model
(Model 6 vs Model 3).
Predicting attendance to second screening using
first screening uptake
When a logistic regression model was applied to predict
second (subsequent) BS uptake using the first BS uptake
as the predictor (Table 6, Model 8), non-attendance was
predicted with an accuracy of 65.4% and attendance was
predicted with an accuracy of 83.8%.
Another model (Model 9) incorporated the Health Be-
liefs and Illness Perception constructs as covariates, to-
gether with the first screening uptake variable as the
main independent variable. Model 9 shows that, follow-
ing the inclusion of all the constructs, ‘Perceived barriers’
and ‘Breast cancer identity’ were found to be important
covariates to improve the accuracy of predicting the at-
tendance to the second screening cycle i.e. 83.8% (Model
8) to 91.9% (Model 9). On the other hand, model accur-
acy dropped from 65.4% (Model 8) to 61.5% (Model 9)
Table 3 Comparison of Illness Perceptions between attendees and non-attendees (Continued)
Attendance to the second breast screening invitation Yes No Total Chi-Square testa
Illness Perception Mean SD Mean SD Mean SD χ2 p-value
You have a clear picture and understanding of Breast Cancer 3.6 0.7 3.7 0.7 3.7 0.7 0.7 0.722
Breast Cancer is a mystery to you 3.2 1.0 3.2 1.0 3.2 1.0 1.3 0.860
You get anxious when you think about Breast Cancer 3.6 1.1 3.7 1.0 3.6 1.1 3.2 0.359
Breast Cancer makes you feel afraid 4.2 0.7 4.3 0.5 4.2 0.7 2.2 0.523
You get worried when you think about Breast Cancer 4.3 0.8 4.4 0.5 4.3 0.7 2.3 0.504
*Significant at α = 0.05
aChi-square test was applied for all illness perceptions; hence the categorical answers were used to apply this test for association. For each question, respondents
were asked to select a number between 1 and 5, where 1 = strongly disagree and 5 = strongly agree
Table 4 Comparisons between health beliefs/illness perception constructs and second breast screening uptake
Range Attendees
(n = 74)
Non-attendees
(n = 26)
Test Statistic p-value
Perceived Susceptibility 3 – 15 M = 9.5, SD = 0.8 M = 9.6, SD = 0.9 1019.5b 0.626
Perceived Benefits 6 - 30 M = 24.0, SD = 1.7 M = 23.6, SD = 1.6 864.0b 0.384
Perceived Barriers 13 – 65 M = 27.0, SD = 4.5 M = 29.2, SD = 6.1 -2.0a 0.049*
Cues to action 7 – 35 M = 27.6, SD = 2.8 M = 25.9, SD = 4.4 726.5b 0.061
Self-Efficacy 7 – 35 M = 24.9, SD = 2.7 M = 24.2, SD = 2.7 783.0b 0.129
Breast Cancer Identity 8 – 40 M = 30.8, SD = 1.9 M = 29.9, SD = 2.5 776.0b 0.124
Causes of Breast Cancer 18 – 90 M = 55.8, SD = 7.2 M = 53.9, SD = 5.9 1.2a 0.238
Cancer Timeline: Acute/Chronic 2 – 10 M = 6.1, SD = 0.8 M = 5.9, SD = 0.8 839.0b 0.295
Cancer Timeline: Cyclical 1 – 5 M = 3.6, SD = 0.7 M = 3.4, SD = 0.7 829.5b 0.221
Consequences 8 – 40 M = 28.8, SD = 2.3 M = 28.1, SD = 1.9 744.0b 0.083
Personal Control 3 – 15 M = 11.9, SD = 0.7 M = 12.0, SD = 0.0 1014.0b 0.432
Treatment Control 3 – 15 M = 10.0, SD = 0.6 M = 9.9, SD = 0.6 865.0b 0.265
Illness Coherence 2 – 10 M = 6.8, SD = 1.2 M = 6.9, SD = 1.1 991.5b 0.802
Emotional Representations 3 – 15 M = 12.1, SD = 2.3 M = 12.4, SD = 1.8 991.5b 0.811
*Significant at α = 0.05
a Independent Samples t-test
b Mann Whitney
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Table 5 Logistic Regression Models on second breast screening uptake against different variables and different constructs
B SE Wald P-value OR 95% CI Model Accuracy
YES
Model Accuracy
NO
Model 1: Demographics 100% 0%
Age -0.154 0.084 3.329 0.068 0.858 0.727, 1.011
Constant 7.926 4.905 2.611 0.106 2769.527
Model 2: Health Status 100% 0%
Breast condition -1.093 0.526 4.315 0.038 0.335 0.119, 0.940
Constant 0.893 0.940 0.902 0.342 2.441
Model 3: Health Beliefs 93.2% 30.8%
No possibility of getting breast cancer 1.064 0.474 5.030 0.025 2.897 1.144, 7.338
Fear of unknown procedurea 0.563 0.388 2.102 0.147 1.755 0.820, 3.756
GP advice -1.145 0.562 4.158 0.041 0.318 0.106, 0.956
Constant 0.480 2.717 0.031 0.860 1.617
Model 4: Illness Perceptions 89.2% 69.2%
Breast swelling, dimpling, redness or soreness
of the skin
-1.796 0.720 6.215 0.013 0.166 0.040, 0.681
Diet -1.029 0.312 10.873 0.001 0.357 0.194, 0.659
Altered immunity 1.462 0.568 6.610 0.010 4.313 1.415, 3.141
Whole life would change -1.334 0.533 6.257 0.012 0.263 0.093, 0.749
Constant 9.082 3.931 5.337 0.021 8796.855
Model 5: Health Beliefs and Illness Perceptions 89.2% 69.2%
Breast swelling, dimpling, redness or soreness
of the skin
-1.796 0.720 6.215 0.013 0.166 0.040, 0.681
Diet -1.029 0.312 10.873 0.001 0.357 0.194, 0.659
Altered immunity 1.462 0.568 6.610 0.010 4.313 1.415, 3.141
Whole life would change -1.334 0.533 6.257 0.012 0.263 0.093, 0.749
Constant 9.082 3.931 5.337 0.021 8796.855
Model 6: Health Beliefs and Illness Perceptions 95.9% 84.6%
Early detection 5.699 2.097 7.390 0.007 298.646 4.904,
18,187.040
If early detection, treatment not as badb 12.267 7.293 2.830 0.093 2.126 ×
105
0.132, 3.427 ×
1011
Having mammography decreases chances of
dyingb
-8.890 6.724 1.748 0.186 0.000 0.000, 72.821
Fear of unknown procedure 5.210 1.842 8.003 0.005 183.103 4.955, 6765.914
Unnecessary radiation 4.471 1.655 7.301 0.007 87.419 3.414, 2238.732
Breast swelling, dimpling, redness or soreness
of the skin
-8.961 3.119 8.252 0.004 0.000 0.000, 0.058
Personality -5.566 2.295 5.885 0.015 0.004 0.000, 0.343
Diet -5.558 1.946 8.160 0.004 0.004 0.000, 0.175
Germ or virus -5.721 2.168 6.967 0.008 0.003 0.000, 0.229
Altered immunity 8.217 2.860 8.254 0.004 3705.048 13.620, 1.008 ×
106
Breast cancer last short time -2.623 1.042 6.340 0.012 0.073 0.009, 0.559
Affects the way others see you 3.105 1.286 5.831 0.016 22.305 1.795, 277.210
Whole life would change -9.738 3.266 8.888 0.003 0.000 0.000, 0.036
You get worried if breast cancer occurs 2.444 1.199 4.159 0.041 11.521 1.100, 120.694
Constant 14.947 26.502 0.318 0.573 3.102 ×
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when predicting non-attendance to the second invitation
at the MBSP.
Discussion
It is not enough to getting women to initiate BS, but it is
essential to encourage them to maintain use over time.
Previous studies have examined re-attendance rates [6,
16, 32]. However, BS statistics are not available
specifically for a second BS invitation. The available
routine BS statistics largely provide cross-sectional
estimates of coverage rather than information on
women’s ongoing attendance at BS [33]. Moreover, data
has long relied on self-reports [34], are measured by
area deprivation (using either residential postcodes or
general practice postcodes) rather than individual
characteristics [35] and can be affected by inflation
based on registered general practice lists [33].
Our preliminary rates for Maltese women invited to
their subsequent call seem to be lower than those in
other countries (Fig. 1: from the total data (n = 100),
62% of Maltese women attended the first and second
round, 9% had attended the first but not the second
round, 17% attended neither call). In a recent study in
London among different ethnic groups [6], white British
women were most likely to attend their first call (67%)
and routine recall (78%). Mixed White and Asian
women had the next highest uptake of routine recall in-
vitations (75%), followed by Indian women (first call
(61%) or routine recall (74%) appointments), Pakistani
(52 and 67%, respectively) and Bangladeshi women (43
and 61%, respectively). The lower subsequent uptake
rates in Malta could be due to the programme being
relatively new. However, we could not find previous
studies that explored re-attendance. We therefore
sought to explore the associations and predictive
psychosocial factors to second screening based on social
cognitive theory.
All sociodemographic characteristics were not signifi-
cantly associated with second screening uptake and the
latter were also found to be non-significant predictors of
second screening to the MBSP. These findings are
substantiated by similar predictors of returning to a
second screen in Australia [16].
More specifically, earlier studies found that women with
a breast problem were more likely to undergo clinical
breast examination (CBE) and mammography than those
Table 5 Logistic Regression Models on second breast screening uptake against different variables and different constructs
(Continued)
B SE Wald P-value OR 95% CI Model Accuracy
YES
Model Accuracy
NO
106
Model 7: The 14 constructs 94.6% 30.0%
Perceived barriers 0.155 0.054 8.305 0.004 0.167 1.051, 1.296
Breast cancer identity -0.231 0.120 3.691 0.055 0.794 0.627, 1.005
Causes of breast cancerc -0.070 0.040 3.022 0.082 0.932 0.861, 1.009
Consequencesc -0.204 0.116 3.082 0.079 0.815 0.649, 1.024
Constant 11.286 4.983 5.129 0.024 79,721.454
B Unstandardized coefficients, SE Standard error, OR Odds ratio, CI Confidence interval
a‘Fear of unknown procedure’ was retained due to better accuracy in the logistic regression model. Without this variable, the accuracy would decrease from 30.8
to 19.2%
b‘If early detection, treatment not bad’ and ‘Having mammography decreases death’ were retained due to better accuracy in the logistic regression model.
Without these variables, the accuracy would decrease from 84.6 to 76.9%
c‘Causes of breast cancer’ and ‘Consequences’ were retained due to better accuracy in the logistic regression model. Without these variables, the accuracy would
decrease from 30.0 to 15.4%
Table 6 Logistic regression analysis on the prediction of second breast screening uptake
B SE Wald P-value OR 95% CI Model Accuracy YES Model Accuracy NO
Model 8: 2nd Screening Uptake 83.8% 65.4%
1st Screening Uptake -2.278 0.519 19.266 0.000 0.102 0.037, 0.283
Constant 0.348 0.377 0.853 0.356 1.417
Model 9: 2nd Screening Uptake 91.9% 61.5%
1st Screening Uptake 2.462 0.571 18.591 0.000 11.728 3.830, 35.914
Perceived barriers 0.129 0.057 5.102 0.024 1.138 1.017, 1.273
Breast cancer identity -0.272 0.123 4.917 0.027 0.762 0.599, 0.969
Constant 0.157 3.730 0.002 0.966 1.170
B Unstandardized coefficients, SE Standard error, OR Odds ratio, CI Confidence interval
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who had none [36, 37], while poor self-rated general
health status was not associated with ever having had a
mammogram in another study [38]. This relationship is
likely driven by higher knowledge levels on the benefits of
BS [36]. In contrast, we did not observe significant
differences between attendees and non-attendees for
self-reported health status in this study, except for those
who claimed they had a breast condition. The latter
women were more likely not to attend for second
screening when compared with those who said they did
not have any breast problem. We are aware that
self-reports may not be as accurate as clinically
documented mammographic reports. Nonetheless, in
view of the nature and organization of the cognitive and
emotional representations of such a health threat, as
proposed by CSM [8, 26, 27], women may have opted to
attend for private mammography [4], possibly as our
earlier study suggests, to obtain an earlier result [7]. Such
reasons for non-attendance to second round screening
merit further investigation in the local context.
This study also provides evidence that women who were
less knowledgeable of the recommended screening fre-
quency were less likely to reattend at the MBSP for a sec-
ond invitation. There is a similar widespread lack of
knowledge of the recommended screening guidelines for a
first BS invitation in Malta [4] and in other countries
[39, 40]. The impact of the physician-patient relationship
may be a reason for the latter finding. In this respect, it is
important to note the variation in the order of invitation
from service to service. For example, in the UK, women
are invited to BS through GP practices [41] whereas in
Malta, women are not registered with GP practices but
are invited to BS according to age cohorts. Possibly, this
infrequent encounter between GPs and Maltese women
(Table 1) may be the reason for physicians’ lack of
opportunity to address knowledge gaps and to
recommend regular BS practices.
Factors associated with BS behaviours in other pop-
ulations [42, 43] were similar to the second BS round
at the MBSP. Namely, Maltese women who believed
that they were susceptible to BC, considered the per-
sonal consequences of the disease, believed that mam-
mography was not painful, and considered cues to
action to motivate them to attend, were more likely
than others to re-attend. Similarly, items for BC
consequences and cues to action as well as
mammography pain were also significantly associated
with first BS uptake at the MBSP. Evidence has
shown that women’s responsibilities within the family
may conflict with self-care and limit screening
attendance and re-attendance [44]. Efforts to educate
health care providers, particularly physicians, should
emphasize the importance of mammography referral
and regular physical check-ups [43].
Of the remaining cognitive variables, perceived BC
susceptibility and attitude towards use predicted attend-
ance to the second BS round, echoing predictors of re-
peat use in other studies [45] while contrasting other
evidence [32]. Attitudes towards BS behaviour and risk
perceptions may be necessary components of why Mal-
tese women contemplate maintaining a behaviour, but
may not be prime motivators to influence the initiation
of that behaviour.
Self-efficacy was not significantly associated with
maintaining BS practices in our study but played a key
role in explaining why some women were unable to ini-
tiate BS at the MBSP [4]. Although previous research
has shown that self-efficacy may be particularly central
in moving women from contemplating about
undergoing mammography to actually obtaining it [46],
in the context of a second BS invitation, the rising
challenges or barriers women experience when trying to
maintain that behaviour may buffer the intentions that
prompt planning for that behaviour [32].
Although several variables differentiated those women
who returned for second round screening in the
programme from those who did not, the ‘perceived bar-
rier’ construct was found to consistently explain the dif-
ferences between attendees and non-attendees and to
improve the accuracy of predicting attendance to the
second screening cycle; a concurrent finding for first
invitation to the MBSP [8]. A trial by Farhadifar and
colleagues [47] also suggests that regular BS practices
are related to fewer barriers. The fact that some women
did not return to their second invitation implies that
based on their first contact with the screening service,
they were less likely to return for routine calls. In the
extant literature, this is attributable to a previous
negative experience [48], possibly due to pain or
discomfort [7, 49], embarrassment, distress, unhelpful
staff and/or lower reassurance during the first screen [50].
Our national data also provides evidence that fear of pain
was a major factor for not attending the first BS invitation
[4] and similarly, this study found pain to be a
significant determinant to non-adherence. Preparing
women through the invitation letter or in screening
campaigns [51] and improving the mammography
experience so that it matches women’s expectations
could help to increase and maintain BS uptake [6].
The inclusion of both Health Beliefs and Illness Per-
ception items in our study improved the accuracy of
predicting non-attendance to the second cycle (Model 6,
84.6%). This finding coincides with findings for first
invitation [4]. Given the importance of both theories and
the higher predictive accuracy for both BS cycles, it is
likely that psychosocial variables, women’s perception of
BC and its related risk, and the enactment of cancer
control measures predict regular BS behaviours [52] in
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an attempt to gain control over the disease [53]. This
sense of internal control has been proven among
disease-effected individuals across diverse health
contexts [22, 54, 55] and healthy individuals [8, 52].
Finally, when considering that only one variable was
utilised to predict second screening uptake, Model 8 can
be considered as an extreme improvement over all the
previous logistic regression models (Table 5). Further-
more, the fact that Model 8 utilised only one predictor
to predict second uptake makes the model more efficient
and easy to use. Moreover, first screening uptake is a
very important and significant predictor to predict future
uptake as this variable does not require any health be-
liefs and/or illness perception variables or any other in-
formation to predict second BS uptake. Our results
further support the evidence that women who obtain at
least one mammogram are more likely to obtain subse-
quent screening [8, 12, 56]. Attendees may be more
aware of the possibility for BC to occur, possibly because
a BC threat (BC identity, causes and consequences
found as CSM predictors for a second BS invitation in
this study), coupled by BS benefits, may have helped the
individual to ascertain what factors pose barriers to BS
attendance and adjust these in the first place. Therefore,
what matters most is the social and psychological char-
acteristics, health behaviours and attitudes which women
bring to screening the first time, such as a positive atti-
tude towards BS, its value, health behaviours and the be-
lief that an individual would be able to overcome any
obstacles to attendance [8, 56]. The most important im-
plication is that if women can be recruited successfully
on the first occasion, they will probably stay in the
programme. Hence, efforts could focus on identifying and
encouraging attendance among women who have never
participated in BS and who are reluctant or unsure to par-
ticipate initially [14] because if women are persuaded to
change their beliefs, attendance rates will increase and
reattendance will become a matter of routine [17].
Strengths and limitations
Our study was not subject to response bias because
figures for re-attendance were extracted from screening
records. This study is one of a few to assess
sociodemographic and attitudinal variables as predictors
of adherence, but we found none that used initial
predictors including HBM and CSM to explore the
second BS round. There are some limitations in our
research. The limited sample size to examine women’s
attendance to a second BS invitation may have reduced
the representativeness of the sample. While the
percentage of women by district or age was similar to
that of the larger study [4], our findings may not be
generalizable to the entire Maltese female population
invited to their second screening. The characteristics of
some women may have changed from first to second
screening; this may have introduced misclassification
and an underestimation of the relationships presented.
Notwithstanding, the study design was necessary for the
feasibility to conduct a prospective study to clarify and
strengthen our findings, based on an understanding of
the culture and attitudes among the Maltese population.
Additional research would help to identify barriers and
reasons influencing decisions about BS maintenance at
the MBSP.
Conclusions
Researchers have focused more often on promoting be-
haviour change than on sustaining change. We explored,
for the first time, the psychosocial associations, differ-
ences and predictors to the second screening invitation
based on demographic factors, health status, knowledge,
health beliefs, illness perceptions, and actual previous
health behaviours. The combination of HBM and CSM
variables provided improved prediction of attendance
and non-attendance to the second screening call.
Perceived barriers, breast cancer identity, causes of BC,
and consequences contributed most to the regression
models, though perceived barriers was consistently
significant across the analyses. Interventions should
particularly target non-attendance to first screening. If
non-attendees can be persuaded to attend once, they are
likely to re-attend, unless their screening experience has
been a negative one. The implications of these results
are considered for theory, policy and practice to improve
the limited understanding of second round screening
and to aid the design of culturally sensitive interventions
to improve breast screening uptake in Malta.
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